Anticorps Recombinant de lapin anti-Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425)
Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) Recombinant Antibody for WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (2)
Applications
WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR
Conjugaison
Non conjugué
CloneNo.
240826D11
N° de cat : 80427-2-RR
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HEK-293 traitées à la calyculine A, |
Résultats positifs en IF/ICC | TGF beta 1 treated HEK-293 cells, |
Résultats positifs en FC (Intra) | cellules HEK-293 traitées à la calyculine A, |
Résultats positifs en ChIP-qPCR | TGF-β1 (7 ng/ml, 1 h) HaCaT cells, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:4000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:250-1:1000 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.13 ug per 10^6 cells in a 100 µl suspension |
CHImmunoprécipitation (IP)-QPCR | CHIP-QPCR : 1:10-1:100 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 7 publications below |
Informations sur le produit
80427-2-RR cible Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) dans les applications de WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Peptide |
Nom complet | SMAD family member 2 |
Masse moléculaire calculée | 467 aa, 52 kDa |
Poids moléculaire observé | 60 kDa |
Numéro d’acquisition GenBank | BC014840 |
Symbole du gène | SMAD2 |
Identification du gène (NCBI) | 4087 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
SMAD2, also named as MADH2 and MADR2, belongs to the dwarfin/SMAD family, contains 1 MH1 (MAD homology 1) domain and 1 MH2 (MAD homology 2) domain. SMAD2 is a receptor-regulated SMAD(R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta and activin type 1 receptor kinases. This protein may act as a tumor suppressor in colorectal carcinoma. It is phosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, It is phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases, and then able to interact with SMURF2, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, it is phosphorylated on Ser-240 by CaMK2. It is phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin. In response to TGF-beta, it is ubiquitinated by NEDD4L, which promotes its degradation. In response to TGF-beta signaling, it is acetylated on Lys-19 by coactivators, which increases transcriptional activity. The molecular weight of unphosphorylated forms of Smad2 is 52 kDa and phosphorylated forms of Smad2 is 58 kDa. (PMID: 9006934)
Protocole
Product Specific Protocols | |
---|---|
WB protocol for Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) antibody 80427-2-RR | Download protocol |
IF protocol for Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) antibody 80427-2-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Phytomedicine ErTao decoction alleviates liver fibrosis by suppressing STING-mediated macrophages and NLRP3 inflammasome activation | ||
Bioeng Transl Med Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway | ||
Sci Rep Autophagy inhibition enhances antifibrotic potential of placental mesenchymal stem cells of fetal origin via regulating TGF-β1 mediated protein degradation of HGF | ||
Eur J Pharmacol Omentin-1 attenuates atrial fibrillation via Src/PI3K/Akt signaling-mediated anti-fibrotic effects in cardiac fibroblasts | ||
Clin Proteomics Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment | ||
Cell Signal CRABP2 promotes peritoneal metastasis in CRC through TGF-β/Smad-mediated EMT signaling and invadopodia formation |